Report cover image

Global Interventional Oncology Ablation Market Growth (Status and Outlook) 2025-2031

Published Sep 10, 2025
Length 92 Pages
SKU # LPI20387768

Description

According to this study, the global Interventional Oncology Ablation market size will reach US$ million by 2031.

Tumor Ablation is a general term for destroying cancer cells. Interventional ablation is a targeted, image-guided therapy for liver, kidney and lung cancers that uses the direct application of extreme heat (radiofrequency and microwave) or cold (cryoablation) to destroy tumor cells. It is most appropriate for small kidney and liver cancers that cannot be removed surgically. In fact, radiofrequency and cryoablation of small kidney cancers have been shown to be just as effective as major surgery.

United States market for Interventional Oncology Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Interventional Oncology Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Interventional Oncology Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Interventional Oncology Ablation players cover Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Interventional Oncology Ablation Industry Forecast” looks at past sales and reviews total world Interventional Oncology Ablation sales in 2024, providing a comprehensive analysis by region and market sector of projected Interventional Oncology Ablation sales for 2025 through 2031. With Interventional Oncology Ablation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Oncology Ablation industry.

This Insight Report provides a comprehensive analysis of the global Interventional Oncology Ablation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Interventional Oncology Ablation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Interventional Oncology Ablation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Oncology Ablation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Oncology Ablation.

This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Oncology Ablation market by product type, application, key players and key regions and countries.

Segmentation by Type:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation

Segmentation by Application:
Hospitals & Clinics
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems, Inc.
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems, Inc.
STARmed Co.
Biomedical Srl

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

92 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Interventional Oncology Ablation Market Size by Player
4 Interventional Oncology Ablation by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Interventional Oncology Ablation Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.